Physician profile
Travis Kliewer
NPI 1629324595
$4,068.39
in general payments reported to CMS, 2019-2025
10 companies · $477 in 2025
The $477 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,623 · 2020: $74.03 · 2021: $328 · 2022: $512 · 2023: $347 · 2024: $709 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,955.26 | 2019-2025 | Myday Contact Lens |
| Alcon Vision LLC | $1,098.18 | 2020-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $413.34 | 2022-2025 | Infuse, Biotrue One Day, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.39 | 2019 | |
| Abb Con-Cise Optical Group LLC | $132.05 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Optos, INC. | $121.31 | 2021-2022 | |
| Allergan, INC. | $67.41 | 2022 | |
| Lombart Brothers, INC. | $64.55 | 2019-2025 | Opd-III |
| Johnson & Johnson Vision Care, INC. | $46.15 | 2019-2024 | |
| Ocular Therapeutix, INC. | $28.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Kliewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.